Broomfield, CO, United States of America

Richard D Woessner

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Array Biopharma Inc.. Active years: 2017.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Richard D. Woessner

Introduction

Richard D. Woessner is a notable inventor based in Broomfield, Colorado. He has made significant contributions to the field of medicine, particularly in the treatment of diseases related to cell division. His innovative approach has led to the development of a unique method that addresses critical health challenges.

Latest Patents

Richard D. Woessner holds a patent for a method of treatment using inhibitors of mitosis. This patent describes methods of treating diseases caused by cell division or that are treated by inhibiting mitosis. The method involves administering two doses of an inhibitor of mitosis between the biologically effective dose and the maximum tolerated dose in a dosing cycle. This cycle allows for the recovery or subsiding of side effects, with the second dose administered 24 to 48 hours after the first dose.

Career Highlights

Woessner is associated with Array Biopharma Inc., a company that focuses on developing targeted therapies for cancer and other diseases. His work at Array Biopharma has been instrumental in advancing treatment options for patients.

Collaborations

Throughout his career, Richard has collaborated with several talented individuals, including Brian J. Tunquist and Duncan Walker. These collaborations have contributed to the success of his innovative projects and the advancement of medical treatments.

Conclusion

Richard D. Woessner's contributions to the field of medicine through his innovative patent demonstrate his commitment to improving health outcomes. His work continues to inspire advancements in treatment methodologies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…